COLEEN COLLINS: Open Payments
NPI 1568810976 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 88 payments from 13 companies in 2025. Trend: 2023 $1,822 · 2024 $1,020 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $276 |
| Neurocrine BioSciences, Inc. | 13 | $248 |
| ABBVIE INC. | 17 | $229 |
| Alkermes, Inc. | 12 | $200 |
| E.R. Squibb & Sons, L.L.C. | 16 | $199 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Teva Pharmaceuticals USA, Inc. | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lundbeck LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
Products named: Auvelity, INGREZZA, VRAYLAR, ARISTADA, COBENFY, ABILIFY ASIMTUFII, UZEDY, CAPLYTA.
Industry payments across FL — which companies pay providers there.
